ORLEU

Reducing Intersectional and HIV Stigma among High Risk Women who use Drugs in Kazakhstan, Central Asia: A Multilevel Stigma Resistance and Enacted Stigma Reduction Intervention for Women and Providers

Study Timeframe: 2022-2025

Principal Investigator:
Victoria Frye, DrPH
Brooke West, PhD (Contact)

Co-investigator(s):
Alissa Davis, PhD
Laura Starbird, PhD

Project director(s):
Meruyert Darisheva

Project Summary

The major goal of the study is to design and assess acceptability, feasibility, and usability of a three component, multi-level participatory intervention to promote stigma resistance/coping and reduce anticipated/internalized stigma among women who exchange sex and use substances, as well as to reduce enacted stigma among HCP in Kazakhstan, Central Asia. Results of this study will generate information in order to power a future preliminary effectiveness trial and will be unique in utilizing multilevel anti-stigma approaches for both women vulnerable to HIV and healthcare providers, all of which will have important implications for advancing HIV prevention and care engagement among highly stigmatized populations in diverse settings.

Our projects have been supported by funding from: